Further supplementary memorandum submitted
by the Department of Health
In his letter of 19 December to Ian Gibson,
the chairman of the committee Sir John Pattison enclosed copies
of the colour coded research networks and also gave the detailed
figures for Government spending on Cancer Research. I think this
covers the first two queries in your letter.
Your letter requested our current estimates
of the Research Networks' staffing requirements. Of the 34 Cancer
Networks, nine became research networks in April last year and
a further nine became research networks in October. Their staffing
requirements vary and are outlined in the strategic plan which
they submit to the National Cancer Research Network Co-ordinating
Centre for approval before being accepted as a Research Network
and receiving core funding. The remaining 16 networks are at varying
stages of making their application for acceptance to be a Research
Network and their staffing requirements are not yet known.
Your letter specifically asked about the level
of spending required to match European spending on cancer services.
Last November the Government published the interim report from
Derek Wanless, Securing our Future Health: Taking a Long-term
View. The report notes that the Department of Health has estimated
that to deliver the NHS Cancer Plan standards aimed at matching
England with the best European standards will require spending
of an additional £1 billion a year spread equally across
screening, treatment and equipment.
You asked for further details regarding the
Statutory Instrument following PIAG's considerations on 10 December.
Draft regulations to be laid under Section 60 of the Health and
Social Care Act 2001 are currently the subject of a public consultation
exercise which ends on 31 January. It is intended that the Patient
Information Advice Group will then submit its advice on the regulations
to the Secretary of State for Health and that the statutory instrument
will be laid before Parliament in February. These regulations
will be subject to annual review.
Professor Mike Richards,
National Cancer Director
21 January 2002